We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comparative analysis of antibody responses to BNT162b2, ChAdOx1, and CoronaVac vaccines in the Albanian population over the pandemic years 2021 to 2022.
- Authors
Sulcebe, Genc; Kurti-Prifti, Margarita; Shyti, Erkena; Dashi-Pasholli, Jonida; Cenko, Fabian; Ylli, Alban
- Abstract
This repeated cross-sectional study with two independent sample populations compared the antibody response to severe acute respiratory syndrome coronavirus 2 vaccines in Albania in July–August 2021 and 2022. In 2021, it found higher anti-spike-1 seropositivity and antibody levels in fully vaccinated individuals, especially with BNT162b2 and ChAdOx1 and to a lesser degree with CoronaVac. By 2022, all single-dose recipients showed high antibody responses, suggesting natural infection-enhanced immunity. The study indicates a significant evolution in the antibody response to different coronavirus disease 2019 vaccines and suggests that a single vaccine dose, coupled with natural infection, might suffice to maintain adequate immunity levels in an endemic scenario.
- Subjects
ALBANIA; SARS-CoV-2; ANTIBODY formation; COVID-19; COVID-19 pandemic; COVID-19 vaccines
- Publication
Clinical & Experimental Vaccine Research, 2024, Vol 13, Issue 1, p63
- ISSN
2287-3651
- Publication type
Article
- DOI
10.7774/cevr.2024.13.1.63